Konstanze Gier

Konstanze Gier is a researcher focused on advancing ex vivo liver models and their applications in drug screening, metabolic disease studies, and toxicological investigations. Her work integrates microfluidics and organ-on-a-chip technologies to create physiologically relevant experimental platforms. Key research interests include bile acid toxicity, metabolic dysfunction-associated liver diseases (MAFLD), and real-time monitoring of cellular metabolism in liver slices. Gier collaborates with experts in hepatology, analytical chemistry, and biomedical engineering to bridge gaps between in vitro models and clinical applications.

Her research outputs highlight innovations such as precision-cut liver slices (PCLS) for disease-in-a-dish systems, oxygen consumption rate analysis via organ-on-a-chip devices, and LC-MS/MS-based toxicological assays. These studies aim to improve drug development pipelines and understand pathophysiological mechanisms in liver disorders. While no specific institutional affiliations are explicitly stated in the provided text, her collaborative projects involve co-authors from diverse disciplines, indicating a networked research environment.

Notable trends in her recent work emphasize translational applications of ex vivo models, with a focus on metabolic disorders and drug-induced liver injury. The integration of advanced technologies like microfluidics reflects her commitment to advancing in vitro systems toward clinical relevance.